newsfilter
← Latest News
ClinicalTrials.gov·

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis - NCT05556096

Change From Baseline in Myasthenia Gravis-Activities of Daily Living (MG-ADL) Total Score at Week 26, Change From Baseline in Quantitative Myasthenia Gravis (QMG) Total Score at Week 26, Percentage of Responders Based on Reduction of the MG-ADL Total Score at Week 26, (and 2 more...)